| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871367 | The Annals of Thoracic Surgery | 2016 | 5 Pages |
Abstract
In our initial experience, DC provided equivalent myocardial protection and clinical outcomes to BC in adult isolated CABG patients. DC was associated with lower cardiopulmonary bypass glucose levels than BC and demonstrated the feasibility of single-dose administration for routine coronary operations.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tomasz MD, Charles MD, Olivia BS, Ben BS, Daniel MD, Andrew MS, Jeff CCP, Dick CCP, Joe CCP,